RCKT Form 144: Insider notice to sell 1,376 shares

RCKT filing of a Form 144 reports proposed sale of 1,376 common shares tied to restricted stock vesting dated 02/13/2026.

Rhea-AI Filing Summary

RCKT filing of a Form 144 reports proposed sale of 1,376 common shares tied to restricted stock vesting dated 02/13/2026. The filing also records prior sales by the reporting person: 1,646 shares on 11/18/2025 and 12,253 shares on 02/13/2026.

Insights

Equity Transactions Analyst

Form 144 lists a proposed sale of 1,376 vested restricted shares and two recent disposals.

The filing shows 1,376 common shares to be sold on 02/13/2026 reported as "Restricted Stock Vesting" with the issuer noted as the source of shares. This indicates the shares became transferable upon vesting.

Prior transactions recorded are 1,646 shares sold on 11/18/2025 and 12,253 shares sold on 02/13/2026. Cash‑flow treatment and purchaser details are not provided in the excerpt; subsequent filings may disclose settlement specifics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the RCKT Form 144 report?

It reports a proposed sale of 1,376 common shares tied to restricted stock vesting on 02/13/2026. The filing also lists prior disposals of 1,646 and 12,253 shares on 11/18/2025 and 02/13/2026 respectively.

Who is the reporting person on the RCKT Form 144?

The excerpt identifies Martin Wilson with an address in Cranbury, NJ as a reporting person. The entry lists his past sales and the current proposed sale tied to restricted stock vesting.

How many shares were sold by the reporting person in the past three months?

The filing shows recent sales totaling 12,253 shares on 02/13/2026 and 1,646 shares on 11/18/2025. These are recorded under 'Securities Sold During The Past 3 Months.'

What is the nature of the shares proposed for sale in the RCKT filing?

The proposed 1,376 common shares are described as resulting from Restricted Stock Vesting on 02/13/2026. The filing lists the issuer as the source of the vested shares.

Does the Form 144 disclose proceeds or purchasers for the RCKT sale?

The provided excerpt does not disclose purchase counterparties or proceeds. The entry lists share counts and dates but omits cash‑flow details and purchaser identities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 04:50 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001704342
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROCKET PHARMACEUTICALS, INC.
SEC File Number	001-36829
Address of Issuer	350 FIFTH AVENUE SUITE 7530 NEW YORK NEW YORK 10118
Phone	646-440-9100
Name of Person for Whose Account the Securities are To Be Sold	Wilson Martin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1376	4593.78	108222228	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Restricted Stock Vesting	Issuer			1376	02/13/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Martin Wilson 9 Cedarbrook Drive Cranbury NJ 08512	Common	11/18/2025	1646	4909.69
Martin Wilson 9 Cedarbrook Drive Cranbury NJ 08512	Common	02/13/2026	12253	40583.16

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Eric Janiak, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Martin Wilson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)